Advertisement
Australia markets closed
  • ALL ORDS

    7,837.40
    -100.10 (-1.26%)
     
  • ASX 200

    7,575.90
    -107.10 (-1.39%)
     
  • AUD/USD

    0.6535
    +0.0012 (+0.18%)
     
  • OIL

    83.66
    +0.09 (+0.11%)
     
  • GOLD

    2,349.60
    +7.10 (+0.30%)
     
  • Bitcoin AUD

    96,578.13
    -1,959.30 (-1.99%)
     
  • CMC Crypto 200

    1,304.48
    -92.06 (-6.59%)
     
  • AUD/EUR

    0.6108
    +0.0035 (+0.57%)
     
  • AUD/NZD

    1.0994
    +0.0037 (+0.33%)
     
  • NZX 50

    11,805.09
    -141.34 (-1.18%)
     
  • NASDAQ

    17,718.30
    +287.79 (+1.65%)
     
  • FTSE

    8,139.83
    +60.97 (+0.75%)
     
  • Dow Jones

    38,239.66
    +153.86 (+0.40%)
     
  • DAX

    18,161.01
    +243.73 (+1.36%)
     
  • Hang Seng

    17,651.15
    +366.61 (+2.12%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

Global Pacemaker Market Size To Hit $6.67 Billion By 2030: Allied Market Research

Rise in prevalence of cardiovascular diseases, technological advancements, demand for minimally invasive procedures, and development of healthcare infrastructure drive the growth of the global pacemaker market. During the pandemic, the non-essential procedures were postponed due to shift in resources to take care of increasing number of patients suffering from the Covid-19 infection. This led to postponement of surgeries related to pacemakers.

Portland, OR, Oct. 18, 2021 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global Pacemaker Market generated $4.66 billion in 2020, and is expected to reach $6.67 billion by 2030, witnessing a CAGR of 3.7% from 2021 to 2030. The report offers a detailed analysis of changing market trends, key segments, top investment pockets, value chain, regional landscape, and competitive scenario.

For Right Perspective and Competitive Insights, Get Sample Report at: https://www.alliedmarketresearch.com/request-sample/1455

Rise in prevalence of cardiovascular diseases, technological advancements, demand for minimally invasive procedures, and development of healthcare infrastructure drive the growth of the global pacemaker market. However, risks and high cost related to procedures hinder the market growth. Contrarily, surge in R&D activities and advancements in technology present new opportunities in the coming years.

ADVERTISEMENT

Covid-19 Scenario:

  • The non-essential procedures were postponed due to shift in resources to take care of increasing number of patients suffering from the Covid-19 infection. This led to postponement of surgeries related to pacemakers. However, the surgeries were carried out in extreme cases.

  • The R&D activities were stopped partially or completely as investments were locked to deal with the economic uncertainties. Moreover, the speed of technological advancements for pacemakers lowered down.

The report offers detailed segmentation of the global pacemaker market based on technology, implantability, end user, and region.

Based on technology, the dual-chamber pacemaker segment held the highest share in 2020, contributing to nearly half of the total share, and is estimated to continue its leadership status during the forecast period. However, the biventricular/CRT pacemaker segment is expected to register the largest CAGR of 5.5% from 2021 to 2030.

Do You Have Any Query Or Specific Requirement? Ask to Our Industry Expert: https://www.alliedmarketresearch.com/purchase-enquiry/1455

Based on end user, the hospital & cardiac centers segment accounted for the largest share in 2020, contributing to more than four-fifths of the global pacemaker market, and is expected to continue its lead in terms of revenue throughout the forecast period. Moreover, this segment is projected to manifest the highest CAGR of 3.9% from 2021 to 2030. The research also analyzes the ambulatory surgical centers segment.

Based on region, Europe contributed to the highest market share in 2020, accounting for nearly half of the total share, and is estimated to maintain its dominance by 2030. However, Asia-Pacific is expected to witness the fastest CAGR of 4.1% during the forecast period.

Leading players of the global pacemaker market analyzed in the research include Abbott Laboratories, Boston Scientific Corporation, BIOTRONIK, Livanova, Lepu Medical, Medtronic, MEDICO SpA, Osypka Medical GmbH, Oscor Inc., and Shree Pacetronix.

Avenue Basic Plan | Library Access | 1 Year Subscription |

Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.

Request for 14 days free trial: https://www.alliedmarketresearch.com/avenue/trial/starter

“We have also published few syndicated market studies in the similar area that might be of your interest. Below are the report title for your reference, considering Impact of Covid-19 Over This Market which will help you to assess aftereffects of pandemic on short-term and long-term growth trends of this market.”

Trending Reports in Healthcare Industry (Book Now with 10% Discount):

Clinical Trial Management (CTM) Market - Global Opportunity Analysis and Industry Forecast, 2020–2028

Medical Simulation Market - Global Opportunity Analysis and Industry Forecast, 2019-2028

Dental Chair Market - Global Opportunity Analysis and Industry Forecast, 2019-2028

U.S. Next Generation Diabetes Therapy and Drug Delivery Market - Global Opportunity Analysis and Industry Forecast, 2019–2028

Dental Liners and Bases Market - Global Opportunity Analysis and Industry Forecast, 2019–2028

Pain Management Devices Market - Global Opportunity Analysis and Industry Forecast, 2019–2028

Injectable Drug Delivery Market - Global Opportunity Analysis and Industry Forecast, 2019–2028

Nebulizer Market - Global Opportunity Analysis and Industry Forecast, 2019–2028

STDs Diagnosis Market - Global Opportunity Analysis and Industry Forecast, 2019–2028

Paediatric Vaccine Market - Global Opportunity Analysis and Industry Forecast, 2019–2028

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

CONTACT: Contact: David Correa 5933 NE Win Sivers Drive #205, Portland, OR 97220 United States USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022 UK: +44-845-528-1300 Hong Kong: +852-301-84916 India (Pune): +91-20-66346060 Fax: +1(855)550-5975 help@alliedmarketresearch.com Web: https://www.alliedmarketresearch.com/reports-store/life-sciences Follow Us on LinkedIn: https://www.linkedin.com/showcase/life-sciences-industry-research/